Canada generics law for poor countries declared ineffective

Two years after Canada suspended patent restrictions to allow generics of certain drugs to be made for poor countries, the plan has been called ineffective by the nation's health minister. Tony Clement said the countries for which the AIDS, malaria and tuberculosis generics were intended have failed to sign up for the offer. And only one drugmaker, Apotex, has taken advantage of the Jean Chretien Pledge to Africa Act by developing a generic drug.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA